Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |